Perfusion NewswireMain ZoneEffect Of New Heparin Potency On Activated Clotting Time During Pediatric Cardiac Surgery: A Retrospective Review (EP Video)
Effect Of New Heparin Potency On Activated Clotting Time During Pediatric Cardiac Surgery: A Retrospective Review (EP Video)
As anticipated, COVID-19 is a pandemic; all healthcare resources are stretched so that ECMO is not a therapy to be rushed to the frontline. Therefore, interim treatment guidelines of recommending ECMO for critically ill COVID-19 patients should be taken cautiously.